Jeil Pharmaceutical Co Ltd (271980) — Capital Reinvestment Ratio
Jeil Pharmaceutical Co Ltd (271980) has a Capital Reinvestment Ratio of 0.27x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩13.23 Billion) in capital expenditures (₩3.55 Billion). See how leveraged is Jeil Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jeil Pharmaceutical Co Ltd Capital Reinvestment Ratio (2018–2024)
This chart tracks Jeil Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 4 annual periods. Check cash flow reinvestment rate of Jeil Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jeil Pharmaceutical Co Ltd (2018–2024)
Year-by-year Capital Reinvestment Ratio for Jeil Pharmaceutical Co Ltd from 2018 to 2024. For live market cap and broader valuation context, see Jeil Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.06x | ₩3.21 Billion | ₩6.61 Billion | ▲ +635.6% |
| 2021 | 0.28x | ₩19.10 Billion | ₩5.34 Billion | ▲ +646.2% |
| 2019 | 0.04x | ₩28.96 Billion | ₩1.09 Billion | ▼ -92.2% |
| 2018 | 0.48x | ₩21.45 Billion | ₩10.29 Billion | — |